Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02048852 · ClinicalTrials.gov registry record · NA
Manipulating Tobacco Constituents in Female Menthol Smokers
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 381
- Enrollment target
NCT02048852: Completed NA study, sponsored by UConn Health.
NCT02048852 is a NA study that has completed, run by UConn Health. The registered enrollment target is 381 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02048852, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 381 participants
- Enrollment target
Study Summary
This study examines the potential effect of reducing nicotine content or menthol or both in women of reproductive age, a vulnerable population identified by the FDA in need of further research.
Primary Outcome
Alter the nicotine and menthol concentrations of cigarettes administered to subjects as randomized.
Interventions
- OTHER Reduced Nicotine Content- Non Menthol
- OTHER Reduced Nicotine Content- Menthol
- OTHER Conventional Nicotine Content- Menthol
- OTHER Conventional Nicotine Content- Non Menthol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 381 participants |
| Start Date | 2014-07 |
| Est. Completion | 2020-07 |
| Phase | NA |
What the finished NCT02048852 record still lists
NCT02048852 is an interventional study that assigns participants to a tested intervention. The registered 381 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 4 interventions - of which Reduced Nicotine Content- Non Menthol is the first listed.
NCT02048852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02048852 about?
NCT02048852 is a clinical study titled "Manipulating Tobacco Constituents in Female Menthol Smokers". This study examines the potential effect of reducing nicotine content or menthol or both in women of reproductive age, a vulnerable population identified by the FDA in need of further research.
What is the current status of trial NCT02048852?
This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2014-07. Estimated completion is 2020-07.
What interventions are being tested in trial NCT02048852?
The interventions under investigation include: Reduced Nicotine Content- Non Menthol (OTHER), Reduced Nicotine Content- Menthol (OTHER), Conventional Nicotine Content- Menthol (OTHER), Conventional Nicotine Content- Non Menthol (OTHER).
Who is sponsoring clinical trial NCT02048852?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02048852's enrollment target sits among peer trials
381 273rd of 2000 higher than 1,728 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia